FORGOTTEN HISTORY: 11 - The Untold Story

Sweeteners and the quest for the perfect alternative to sugar

Designing a series of sweetener trials seemed straightforward enough to us as behavioural scientists who specialise in human appetite and obesity. The plan was simple: replace the added sugar in a range of foods with different classes of alternative sweeteners, holding everything else constant.

The Conversation · May 15

Weight loss drugs could ease migraine pain and reduce asthma symptoms, experts say

Two separate studies revealed that people using the drugs had reported less asthma flare-ups and a reduction in prescriptions for a type of migraine medication

The Independent UK · May 14

The weight loss method proven to help you shed pounds and keep them off

The research ‘challenges the longstanding assumption that gradual weight loss is superior’

The Independent UK · May 14

The Mona Lisa likely ‘put on weight in pregnancy’ – why it could change doctors’ views on obesity

Learning about art history could help counter stigma around being overweight

The Independent UK · May 13

Art history ‘could help medics be less judgmental when it comes to obesity’

Obesity was viewed as a sign of wealth for centuries, and future art may depict gaunt faces caused by rapid weight loss from GLP-1 drugs.

Evening Standard · May 13

How UK obesity rates compare to other high-income western nations

IN FULL

The Independent UK · May 13

Experts reveal the good and bad news about Britain’s obesity rates – and the role weight loss jabs will have

The UK remains mostly in the top 10 countries among high-income western nations for obesity rates, researchers said

The Independent UK · May 13

Obesity rates in some countries levelling off or potentially falling, study finds

Researchers say rise not inevitable and it is important to unpick what is behind differences in obesity trends

The Guardian - UK · May 13

Novo Nordisk A/S Q1 Earnings Call Highlights

Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity franchise and a series of pipeline and regulatory milestones, even as adjusted sales declined because of lower realized prices. Chi

MarketBeat · May 13

Lift safety warning as its claimed capacity limits ‘have not risen with obesity’

Average weight of men and women has increased since the mid 1970s, sparking lift safety concerns

The Independent UK · May 12